ABCG2 and chronic kidney disease: This study aimed to evaluate age- versus CKD-related changes in the activity of CYP3A and the drug transporters, P-gp, OATP, and BCRP, using a microdose cocktail in the elderly with and without CKD compared to young healthy participants.